Pfizer Gets New Trial After $39M Trade Secrets Verdict

Law360, New York (February 26, 2013, 11:31 PM EST) -- Pfizer Inc. will get a new trial after losing a $39 million dispute over trade secrets it allegedly stole from a California-based research group, when a California appeals court on Tuesday affirmed a lower court’s decision to grant the drug giant another shot.

The panel found that the research group The Ischemia Research and Education Foundation had brought up only its own evidence in its appeal of the lower court’s decision, and ruled that it did not do enough to counter Pfizer’s conflicting evidence that showed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.